398 related articles for article (PubMed ID: 30448285)
1. Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice.
Arrant AE; Filiano AJ; Patel AR; Hoffmann MQ; Boyle NR; Kashyap SN; Onyilo VC; Young AH; Roberson ED
Neurobiol Dis; 2019 Apr; 124():152-162. PubMed ID: 30448285
[TBL] [Abstract][Full Text] [Related]
2. Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis.
Arrant AE; Onyilo VC; Unger DE; Roberson ED
J Neurosci; 2018 Feb; 38(9):2341-2358. PubMed ID: 29378861
[TBL] [Abstract][Full Text] [Related]
3. Conditional loss of progranulin in neurons is not sufficient to cause neuronal ceroid lipofuscinosis-like neuropathology in mice.
Petkau TL; Blanco J; Leavitt BR
Neurobiol Dis; 2017 Oct; 106():14-22. PubMed ID: 28647554
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice.
Filiano AJ; Martens LH; Young AH; Warmus BA; Zhou P; Diaz-Ramirez G; Jiao J; Zhang Z; Huang EJ; Gao FB; Farese RV; Roberson ED
J Neurosci; 2013 Mar; 33(12):5352-61. PubMed ID: 23516300
[TBL] [Abstract][Full Text] [Related]
5. Selective depletion of microglial progranulin in mice is not sufficient to cause neuronal ceroid lipofuscinosis or neuroinflammation.
Petkau TL; Kosior N; de Asis K; Connolly C; Leavitt BR
J Neuroinflammation; 2017 Nov; 14(1):225. PubMed ID: 29149899
[TBL] [Abstract][Full Text] [Related]
6. Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations.
Arrant AE; Roth JR; Boyle NR; Kashyap SN; Hoffmann MQ; Murchison CF; Ramos EM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Roberson ED
Acta Neuropathol Commun; 2019 Dec; 7(1):218. PubMed ID: 31870439
[TBL] [Abstract][Full Text] [Related]
7. Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia.
Arrant AE; Filiano AJ; Unger DE; Young AH; Roberson ED
Brain; 2017 May; 140(5):1447-1465. PubMed ID: 28379303
[TBL] [Abstract][Full Text] [Related]
8. Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice.
Götzl JK; Colombo AV; Fellerer K; Reifschneider A; Werner G; Tahirovic S; Haass C; Capell A
Mol Neurodegener; 2018 Sep; 13(1):48. PubMed ID: 30180904
[TBL] [Abstract][Full Text] [Related]
9. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.
Arrant AE; Nicholson AM; Zhou X; Rademakers R; Roberson ED
Mol Neurodegener; 2018 Jun; 13(1):32. PubMed ID: 29929528
[TBL] [Abstract][Full Text] [Related]
10. Network analysis of the progranulin-deficient mouse brain proteome reveals pathogenic mechanisms shared in human frontotemporal dementia caused by GRN mutations.
Huang M; Modeste E; Dammer E; Merino P; Taylor G; Duong DM; Deng Q; Holler CJ; Gearing M; Dickson D; Seyfried NT; Kukar T
Acta Neuropathol Commun; 2020 Oct; 8(1):163. PubMed ID: 33028409
[TBL] [Abstract][Full Text] [Related]
11. Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic.
Logan T; Simon MJ; Rana A; Cherf GM; Srivastava A; Davis SS; Low RLY; Chiu CL; Fang M; Huang F; Bhalla A; Llapashtica C; Prorok R; Pizzo ME; Calvert MEK; Sun EW; Hsiao-Nakamoto J; Rajendra Y; Lexa KW; Srivastava DB; van Lengerich B; Wang J; Robles-Colmenares Y; Kim DJ; Duque J; Lenser M; Earr TK; Nguyen H; Chau R; Tsogtbaatar B; Ravi R; Skuja LL; Solanoy H; Rosen HJ; Boeve BF; Boxer AL; Heuer HW; Dennis MS; Kariolis MS; Monroe KM; Przybyla L; Sanchez PE; Meisner R; Diaz D; Henne KR; Watts RJ; Henry AG; Gunasekaran K; Astarita G; Suh JH; Lewcock JW; DeVos SL; Di Paolo G
Cell; 2021 Sep; 184(18):4651-4668.e25. PubMed ID: 34450028
[TBL] [Abstract][Full Text] [Related]
12. Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTD.
Wu Y; Shao W; Todd TW; Tong J; Yue M; Koga S; Castanedes-Casey M; Librero AL; Lee CW; Mackenzie IR; Dickson DW; Zhang YJ; Petrucelli L; Prudencio M
Cell Rep; 2021 Aug; 36(8):109581. PubMed ID: 34433069
[TBL] [Abstract][Full Text] [Related]
13. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia.
Holler CJ; Taylor G; McEachin ZT; Deng Q; Watkins WJ; Hudson K; Easley CA; Hu WT; Hales CM; Rossoll W; Bassell GJ; Kukar T
Mol Neurodegener; 2016 Jun; 11(1):46. PubMed ID: 27341800
[TBL] [Abstract][Full Text] [Related]
14. Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients.
Valdez C; Wong YC; Schwake M; Bu G; Wszolek ZK; Krainc D
Hum Mol Genet; 2017 Dec; 26(24):4861-4872. PubMed ID: 29036611
[TBL] [Abstract][Full Text] [Related]
15. Genetic Regulation of Neuronal Progranulin Reveals a Critical Role for the Autophagy-Lysosome Pathway.
Elia LP; Mason AR; Alijagic A; Finkbeiner S
J Neurosci; 2019 Apr; 39(17):3332-3344. PubMed ID: 30696728
[TBL] [Abstract][Full Text] [Related]
16. Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.
Ward ME; Chen R; Huang HY; Ludwig C; Telpoukhovskaia M; Taubes A; Boudin H; Minami SS; Reichert M; Albrecht P; Gelfand JM; Cruz-Herranz A; Cordano C; Alavi MV; Leslie S; Seeley WW; Miller BL; Bigio E; Mesulam MM; Bogyo MS; Mackenzie IR; Staropoli JF; Cotman SL; Huang EJ; Gan L; Green AJ
Sci Transl Med; 2017 Apr; 9(385):. PubMed ID: 28404863
[TBL] [Abstract][Full Text] [Related]
17. AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated Toxicity.
Amado DA; Rieders JM; Diatta F; Hernandez-Con P; Singer A; Mak JT; Zhang J; Lancaster E; Davidson BL; Chen-Plotkin AS
Mol Ther; 2019 Feb; 27(2):465-478. PubMed ID: 30559071
[TBL] [Abstract][Full Text] [Related]
18. Progranulin haploinsufficiency mediates cytoplasmic TDP-43 aggregation with lysosomal abnormalities in human microglia.
Sung W; Noh MY; Nahm M; Kim YS; Ki CS; Kim YE; Kim HJ; Kim SH
J Neuroinflammation; 2024 Feb; 21(1):47. PubMed ID: 38347588
[TBL] [Abstract][Full Text] [Related]
19. Progranulin as a therapeutic target in neurodegenerative diseases.
Rhinn H; Tatton N; McCaughey S; Kurnellas M; Rosenthal A
Trends Pharmacol Sci; 2022 Aug; 43(8):641-652. PubMed ID: 35039149
[TBL] [Abstract][Full Text] [Related]
20. Microglial NFκB-TNFα hyperactivation induces obsessive-compulsive behavior in mouse models of progranulin-deficient frontotemporal dementia.
Krabbe G; Minami SS; Etchegaray JI; Taneja P; Djukic B; Davalos D; Le D; Lo I; Zhan L; Reichert MC; Sayed F; Merlini M; Ward ME; Perry DC; Lee SE; Sias A; Parkhurst CN; Gan WB; Akassoglou K; Miller BL; Farese RV; Gan L
Proc Natl Acad Sci U S A; 2017 May; 114(19):5029-5034. PubMed ID: 28438992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]